Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior TreatmentNeoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Nerve Tissue, central nervous system cancer, intracranial meningioma, meningioma, neoplasm, nervous system disorder, tumor of meninges, vascular cancerRecruitingPhase 22026-10-02NCT06955169

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Novartis Pharmaceuticals432
RTOG Foundation, Inc.5

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Baptist Health Medical Group OncologyMiamiUnited States2
Baptist MD Anderson Cancer CenterJacksonvilleUnited States72
Dana-Farber/Harvard Cancer CenterBostonUnited States3
Duke University Medical CenterDurhamUnited States1
Henry Ford HospitalDetroitUnited States326
Indiana UniversityIndianapolisUnited States160
MD Anderson Cancer CenterHoustonUnited States589
Medical College of WisconsinMilwaukeeUnited States483
Moffitt Cancer CenterTampaUnited States1
NYU Lagone HealthNew YorkUnited States2
Piedmont HealthcareAtlantaUnited States13
University of California San Diego - Moores Cancer CenterLa JollaUnited States3
University of California, IrvineIrvineUnited States32
University of Iowa Health CareIowa CityUnited States47
University of MiamiMiamiUnited States22
University of Michigan Rogel Cancer CenterAnn ArborUnited States186
Yale UniversityNew HavenUnited States352